Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$3.29 - $12.99 $5.08 Million - $20.1 Million
1,543,500 Added 488.96%
1,859,168 $21.1 Million
Q3 2023

Nov 13, 2023

SELL
$0.74 - $8.5 $2.1 Million - $24.1 Million
-2,841,031 Reduced 90.0%
315,668 $1.27 Million
Q1 2021

Aug 12, 2021

BUY
$17.65 - $24.16 $4.15 Million - $5.68 Million
235,294 Added 8.05%
3,156,699 $66 Million
Q1 2019

Jun 04, 2019

BUY
$9.47 - $17.01 $6.4 Million - $11.5 Million
676,184 Added 30.12%
2,921,405 $27.7 Million
Q1 2019

May 15, 2019

BUY
$9.47 - $17.01 $21.3 Million - $38.2 Million
2,245,221 New
2,245,221 $21.3 Million

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.